Avoidance of drug interactions with hepatitis C treatment: Evaluation of pharmacist interventions in the specialty setting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Avoidance of drug interactions with hepatitis C treatment: Evaluation of pharmacist interventions in the specialty setting

Published:2022-09 Issue:5 Volume:62 Page:1671-1674
ISSN:1544-3191
Container-title:Journal of the American Pharmacists Association
language:en
Short-container-title:Journal of the American Pharmacists Association

Author:

Huntley Madison,McCall Kenneth,Stickney Kirsten,Gelinas Alycia^ORCID,Levesque Eileen

Publisher

Elsevier BV

Subject

Pharmacology,Pharmacy,Pharmacology (nursing)

Reference11 articles.

1. Drug-drug interactions potential of direct-acting antivirals for the treatment of chronic hepatitis C virus infection;Néant;Int J Antimicrob Agents,2020

2. Harvoni (Ledipasvir and Sofosbuvir Tablet) [Package Insert],2021

3. Epclusa (Velpatasvir and Sofosbuvir Tablet) [Package Insert],2021

4. Drug-drug interactions between direct-acting antivirals and statins in the treatment of chronic hepatitis C;Kuo;Tzu Chi Med J,2020

5. Economic evaluations of clinical pharmacy services: 2006-2010;Touchette;Pharmacotherapy,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP